ROPINIROLE TEVA 1 mg, film-coated tablet 21 tablets
Active ingredients: Ropinirole hydrochloride, Ropinirol
Commercialized according to BDPMANSM noticeDispensing in France: Prescription only
Film-coated tablet21 tabletsorale
Supply disruption
Package details
Original BDPM fields are shown in French.
- Official name
- ROPINIROLE TEVA 1 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- plaquette(s) thermoformée(s) aluminium polyamide PVC-Aluminium de 21 comprimé(s)
- Marketing authorisation holder
- TEVA SANTE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 15 Apr 2010
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
61197676CIP73930484CIP133400939304847Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CHLORHYDRATE DE ROPINIROLEcomprimé | 1,14 mg · un comprimé | SA |
| ROPINIROLE BASEcomprimé | 1 mg · un comprimé | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.